Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review.
about
Biologic therapies and bone loss in rheumatoid arthritis.The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting.Metabolomic profiling predicts outcome of rituximab therapy in rheumatoid arthritis.Personalized medicine in rheumatology: the paradigm of serum autoantibodies.Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis.
P2860
Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Anti-citrullinated peptide ant ...... to biologic agents: a review.
@en
type
label
Anti-citrullinated peptide ant ...... to biologic agents: a review.
@en
prefLabel
Anti-citrullinated peptide ant ...... to biologic agents: a review.
@en
P2093
P2860
P1476
Anti-citrullinated peptide ant ...... to biologic agents: a review.
@en
P2093
Alejandro Balsa
Estíbaliz Loza
Juan Gómez-Reino
Miguel Angel González-Gay
Rosario García-Vicuna
P2860
P2888
P304
P356
10.1007/S00296-016-3506-3
P577
2016-06-06T00:00:00Z
P6179
1027268356